Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,616.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
93.81
(
2.68%
)
Bitcoin
72,775.99
(
-1.06%
)
News Focus
News Focus
Post# of 518983
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Investor2014

Send PM Follow Ignore
Followers 65
Posts 27910
Boards Moderated 0
Alias Born 11/23/2016

Investor2014

Re: Bourbon_on_my_cornflakes post# 328089

Sunday, 08/29/2021 3:35:10 PM

Sunday, August 29, 2021 3:35:10 PM

Post# of 518983
History of Changes for Study: NCT03790709 ANAVEX2-73 for Treatment of Early Alzheimer's Disease

When you follow this link you will see a side-by-side comparison of the original and latest updated records of the AD P2b/3 trial.

The trial always anticipated to enroll 450 patients. There is no such thing as a separate 225 person Australian trial, just continuous enrolment with the first sites initiated in Australia followed overtime by Europe and North America.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News